Search research articles
Contact Us
Filters
Showing results (51-60 of 113) with videos related to
Page
of 12
Sort By:
The Psychiatric Quarterly
|
January 25, 2008
Comparison of clozapine response for inpatients in the research setting versus routine clinical practice
Douglas L Boggs, Deanna L Kelly, Raymond C Love, et al.
Neuropsychiatric Disease and Treatment
|
June 30, 2012
Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis
Wenyu Ye, Haya Ascher-Svanum, Yuka Tanji, et al.
Journal of Psychopharmacology (Oxford, England)
|
September 11, 2004
The effects of clozapine and high-dose olanzapine on brain function in treatment-resistant schizophrenia: a case study
Robert R Conley, Deanna L Kelly, Lori L Beason-Held, et al.
CNS Drugs
|
March 24, 2026
Intranasal 5-MeO-DMT Concomitant with SSRI for Treatment-Resistant Depression: A Proof-of-Concept Trial
Mathieu Seynaeve, Fiona Dunbar, Chandni Hindocha, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 3, 2002
Novel factor-based symptom scores in treatment resistant schizophrenia: implications for clinical trials
Robert P McMahon, Deanna L Kelly, Julie Kreyenbuhl, et al.
The International Journal of Neuropsychopharmacology
|
September 19, 2006
Cyclic AMP response element-binding protein in post-mortem brain of teenage suicide victims: specific decrease in the prefrontal cortex but not the hippocampus
Ghanshyam N Pandey, Yogesh Dwivedi, Xinguo Ren, et al.
JAMA Neurology
|
May 30, 2018
Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial
Virginia L Stauffer, David W Dodick, Qi Zhang, et al.
Biological Psychiatry
|
December 24, 2008
Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis
William T Regenold, Pornima Phatak, Christopher M Marano, et al.
Comprehensive Psychiatry
|
November 9, 2005
Cardiovascular disease in relation to weight in deceased persons with schizophrenia
Robert R Conley, Joo-Cheol Shim, Deanna L Kelly, et al.
The Psychiatric Quarterly
|
January 7, 2006
Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia
Deanna L Kelly, Robert R Conley, Stephanie Feldman, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 113) with videos related to
Sort By:
Page
of 12
The Psychiatric Quarterly
|
January 25, 2008
Comparison of clozapine response for inpatients in the research setting versus routine clinical practice
Douglas L Boggs, Deanna L Kelly, Raymond C Love, et al.
Neuropsychiatric Disease and Treatment
|
June 30, 2012
Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis
Wenyu Ye, Haya Ascher-Svanum, Yuka Tanji, et al.
Journal of Psychopharmacology (Oxford, England)
|
September 11, 2004
The effects of clozapine and high-dose olanzapine on brain function in treatment-resistant schizophrenia: a case study
Robert R Conley, Deanna L Kelly, Lori L Beason-Held, et al.
CNS Drugs
|
March 24, 2026
Intranasal 5-MeO-DMT Concomitant with SSRI for Treatment-Resistant Depression: A Proof-of-Concept Trial
Mathieu Seynaeve, Fiona Dunbar, Chandni Hindocha, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
April 3, 2002
Novel factor-based symptom scores in treatment resistant schizophrenia: implications for clinical trials
Robert P McMahon, Deanna L Kelly, Julie Kreyenbuhl, et al.
The International Journal of Neuropsychopharmacology
|
September 19, 2006
Cyclic AMP response element-binding protein in post-mortem brain of teenage suicide victims: specific decrease in the prefrontal cortex but not the hippocampus
Ghanshyam N Pandey, Yogesh Dwivedi, Xinguo Ren, et al.
JAMA Neurology
|
May 30, 2018
Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial
Virginia L Stauffer, David W Dodick, Qi Zhang, et al.
Biological Psychiatry
|
December 24, 2008
Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis
William T Regenold, Pornima Phatak, Christopher M Marano, et al.
Comprehensive Psychiatry
|
November 9, 2005
Cardiovascular disease in relation to weight in deceased persons with schizophrenia
Robert R Conley, Joo-Cheol Shim, Deanna L Kelly, et al.
The Psychiatric Quarterly
|
January 7, 2006
Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia
Deanna L Kelly, Robert R Conley, Stephanie Feldman, et al.
Page
of 12